Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Transplant nephrology
How do you approach the management of patients with primary membranous nephropathy and a positive anti-PLA2R antibody test who are being considered for kidney transplantation?
Related Questions
What is the best way to assess exercise capacity in kidney transplantation candidates to predict post-transplant outcomes?
Do you have specific waiting periods before a patient can be listed for a kidney transplant if they have a past history of malignancy?
How do you approach kidney transplant evaluation and management in an ESKD patient with a history of anti-GBM disease and currently detectable anti-GBM antibodies?
How much proteinuria would warrant consideration of native kidney nephrectomies at the time of a kidney transplant?
Would you rely on virtual crossmatch alone to proceed with a kidney transplant?
When do you use ambulatory blood pressure monitoring to assess hypertension in a living kidney donor candidate?
When do you recommend genetic testing prior to kidney transplantation for a patient with ESKD secondary to FSGS?
How do you distinguish TMA caused by CNI toxicity versus antibody mediated rejection in a kidney transplant patient?
What is your strategy to manage the complication of long-term immunosuppression in liver transplant recipients, specifically renal dysfunction and onset of cardiometabolic comorbidities?
What is your approach to managing a kidney transplant patient who develops BK viremia after treatment for rejection?
